{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:58:34Z","timestamp":1791374314204,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jacl.2025.09.020","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:47:58Z","timestamp":1758602878000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative outcomes of moderate-intensity statin with ezetimibe vs high-intensity statin therapy: A retrospective observational cohort study"],"prefix":"10.1016","volume":"20","author":[{"given":"Junpil","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokhun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doyeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Mo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-0747","authenticated-orcid":false,"given":"Jung-Kyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.09.020_bib0001","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.09.020_bib0002","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2025.09.020_bib0003","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.09.020_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.09.020_bib0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11883-023-01124-z","article-title":"Statin intolerance: an overview of US and international guidance","volume":"25","author":"Cheeley","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2025.09.020_bib0006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/14779072.2023.2215982","article-title":"Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management","volume":"21","author":"Iatan","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacl.2025.09.020_bib0007","article-title":"Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level >\/= 190 mg\/dL: a retrospective cohort study","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2025.09.020_bib0008","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amjcard.2006.08.051","article-title":"Safety and efficacy of statins in Asians","volume":"99","author":"Liao","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2025.09.020_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5551\/jat.RV16004","article-title":"Racial differences in the cholesterol-lowering effect of statin","volume":"24","author":"Naito","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2025.09.020_bib0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1186\/s12872-024-04144-y","article-title":"The clinical effectiveness and safety of low\/moderate-intensity statins & ezetimibe combination therapy versus. high-intensity statin monotherapy: a systematic review and meta-analysis","volume":"24","author":"Sydhom","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacl.2025.09.020_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/XCE.0000000000000315","article-title":"Efficacy and safety of double-dose statin monotherapy versus moderate-intensity statin combined with ezetimibe dual therapy in diabetic patients: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Goyal","year":"2024","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"10.1016\/j.jacl.2025.09.020_bib0012","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4093\/dmj.2023.0171","volume":"47","author":"Moon","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jacl.2025.09.020_bib0013","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12997\/jla.2023.12.3.277","article-title":"Lipid-lowering efficacy of combination therapy with moderate-intensity statin and Ezetimibe versus high-intensity statin monotherapy: A randomized, open-label, non-inferiority trial from Korea","volume":"12","author":"Choi","year":"2023","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacl.2025.09.020_bib0014","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","article-title":"Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial","volume":"400","author":"Kim","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2025.09.020_bib0015","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.3346\/jkms.2020.35.e222","article-title":"Comparison of serum uric acid in major depressive disorder and bipolar disorder: a retrospective chart review study","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jacl.2025.09.020_bib0016","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.3346\/jkms.2020.35.e402","article-title":"Comparison of suicide risk by mental illness: a retrospective review of 14-year electronic medical records","volume":"35","author":"Song","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jacl.2025.09.020_bib0017","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2025.09.020_bib0018","doi-asserted-by":"crossref","first-page":"208","DOI":"10.12997\/jla.2019.8.2.208","article-title":"Intensity of statin treatment in Korean patients with acute myocardial infarction and very low LDL cholesterol","volume":"8","author":"Sim","year":"2019","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacl.2025.09.020_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075837","article-title":"Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial","volume":"383","author":"Lee","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2025.09.020_bib0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jama.2023.2487","article-title":"Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial","volume":"329","author":"Hong","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2025.09.020_bib0021","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.09.020_bib0022","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.09.020_bib0023","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2025.09.020_bib0024","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2023.02.007","article-title":"Combination moderate-intensity statin and Ezetimibe therapy for elderly patients with atherosclerosis","volume":"81","author":"Lee","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.09.020_bib0025","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.09.020_bib0026","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2009.09.010","volume":"54","author":"Gibson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.09.020_bib0027","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jacl.2025.09.020_bib0028","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","article-title":"Diabetes mellitus and inflammation","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jacl.2025.09.020_bib0029","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000508886","article-title":"Comparison of intravascular ultrasound virtual histology parameters in diabetes versus non-diabetes with acute coronary syndrome","volume":"145","author":"Reddy","year":"2020","journal-title":"Cardiology"},{"key":"10.1016\/j.jacl.2025.09.020_bib0030","doi-asserted-by":"crossref","first-page":"f2610","DOI":"10.1136\/bmj.f2610","article-title":"Risk of incident diabetes among patients treated with statins: population based study","volume":"346","author":"Carter","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2025.09.020_bib0031","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742500409X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742500409X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:46:47Z","timestamp":1791373607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742500409X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S193328742500409X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.09.020","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative outcomes of moderate-intensity statin with ezetimibe vs high-intensity statin therapy: A retrospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}